Breaking News
Get 40% Off 0
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2? Unlock full list
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gilead's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
68.07 -0.58    -0.84%
21:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
67.89
-0.18
-0.26%
22:09:07 - Real-time Data
  • Volume: 5,227,328
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 67.62 - 68.48
Type:  Equity
Market:  United States
Gilead 68.07 -0.58 -0.84%

GILD Recent Sentiments

 
User's sentiments regarding Gilead shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect GILD shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Gilead.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 12, 2024 Michael Kennedy   67.93 +0.21%
Apr 12, 2024 Daniel Poulin   68.37 -0.44%
Apr 11, 2024 Manuel Capsoni   68.59 -0.76%
Apr 10, 2024 Jovica Palashevski   68.42 -0.51%
Apr 10, 2024 ROBERTO PROIETTI   68.43 -0.53%
Apr 09, 2024 miguel mourao   69.70 -2.34%
Apr 05, 2024 Nurik Sarsenov   69.63 -2.24%
Apr 05, 2024 miguel Ribero   69.70 Apr 08, 2024 @ 69.23 +0.67%
Apr 04, 2024 Ashok Patel   70.04 -2.81%
Apr 04, 2024 CARLOS ALBERTO ELORZA   70.60 Apr 08, 2024 @ 69.23 -1.94%
Apr 04, 2024 Михаил K   70.85 Apr 04, 2024 @ 70.84 -0.01%
Apr 03, 2024 Yesim Giray   71.64 +4.98%
Apr 02, 2024 Tommy XXX   72.00 Apr 08, 2024 @ 69.23 -3.85%
Apr 02, 2024 Vanja Fike   72.85 Apr 08, 2024 @ 69.23 -4.97%
Apr 01, 2024 abderrahmane bennani   72.77 +6.46%
Apr 01, 2024 Sergio BS   72.77 -6.46%
Mar 28, 2024 Fred Ames   73.45 Apr 01, 2024 @ 72.72 -0.99%
Mar 27, 2024 Francisco Leon   72.72 -6.39%
Mar 26, 2024 bill newman   72.30 Apr 01, 2024 @ 72.72 -0.58%
Mar 21, 2024 Jan Zinserling   73.65 Mar 25, 2024 @ 72.67 -1.33%
Mar 15, 2024 spoo ok   73.73 Mar 20, 2024 @ 73.41 +0.43%
Mar 12, 2024 Лёша Ахремчик   74.97 Apr 05, 2024 @ 69.58 -7.19%
Mar 12, 2024 Florin M Pop   75.49 Mar 18, 2024 @ 73.86 -2.16%
Mar 11, 2024 Tito turavinin   75.39 Apr 05, 2024 @ 69.58 -7.71%
Mar 11, 2024 El Soriano Solitario...   75.48 Apr 05, 2024 @ 69.58 -7.82%
Mar 06, 2024 Maxime Roux Dubois   72.69 Mar 29, 2024 @ 73.25 +0.77%
Mar 06, 2024 JOSE LUIS GARCIA   72.82 Mar 29, 2024 @ 73.25 +0.59%
Mar 05, 2024 Simon Tognola   72.62 Mar 29, 2024 @ 73.25 +0.87%
Feb 29, 2024 elie badaoui   72.14 Mar 22, 2024 @ 72.61 +0.65%
Feb 29, 2024 Daniel Sosa   72.01 Mar 04, 2024 @ 72.18 -0.24%
Feb 28, 2024 Antonio Murillo   73.00 Mar 04, 2024 @ 72.18 -1.12%
Feb 27, 2024 فواز الحربي   72.98 Mar 22, 2024 @ 72.61 -0.51%
Feb 27, 2024 Claudio Mosconi   72.79 Mar 22, 2024 @ 72.61 -0.25%
Feb 27, 2024 Regev Oded   72.95 Mar 04, 2024 @ 72.18 -1.06%
Feb 26, 2024 지연 한   73.79 Mar 22, 2024 @ 72.61 -1.60%
Feb 26, 2024 Dietmar Knoch   73.61 Mar 04, 2024 @ 72.18 -1.94%
Feb 22, 2024 אריה אחישר   72.37 Mar 15, 2024 @ 73.69 +1.82%
Feb 21, 2024 mohamed mohsen   72.94 Feb 26, 2024 @ 72.88 -0.08%
Feb 21, 2024 Antonio Murillo   73.06 Feb 26, 2024 @ 72.88 -0.25%
Feb 21, 2024 Artur Kubit   72.54 Feb 26, 2024 @ 72.88 +0.47%
Feb 16, 2024 Yury Titov   71.97 Mar 08, 2024 @ 75.12 +4.38%
Feb 16, 2024 Kirill Melnik   71.83 Mar 08, 2024 @ 75.12 +4.58%
Feb 16, 2024 דויד 1   72.03 Mar 08, 2024 @ 75.12 +4.29%
Feb 16, 2024 Francisco Moreno   72.11 Mar 08, 2024 @ 75.12 +4.17%
Feb 15, 2024 Yasmina Raupova   73.33 Mar 08, 2024 @ 75.12 +2.44%
Feb 14, 2024 Dietmar Knoch   73.73 Feb 19, 2024 @ 71.58 -2.92%
Feb 13, 2024 isabelle torrell   73.47 Feb 19, 2024 @ 71.58 -2.57%
Feb 13, 2024 Fernando Sala   73.47 Mar 08, 2024 @ 75.12 +2.25%
Feb 12, 2024 Salim Kutchi   74.07 Mar 08, 2024 @ 75.12 +1.42%
Feb 09, 2024 carlos coutinho   73.80 Mar 01, 2024 @ 72.31 -2.02%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Price Commentary

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email